Literature DB >> 15812151

Gastric cancer: who is at risk?

Rocco Maurizio Zagari1, Franco Bazzoli.   

Abstract

Gastric cancer is a multifactorial disease. Helicobacter pylori infection, host genetic factors and dietetic factors play an important role in the development of gastric cancer. Individuals with a positive family history of gastric cancer and/or pro-inflammatory polymorphisms of the interleukin-1 and tumor necrosis factor A genes infected by H. pylori virulent strains (cagA-, vacA s1-, vacA m1- and babA2-positive) have the highest risk of gastric cancer development. Diets rich in salted and smoked food and poor in fresh fruit and vegetables favor gastric carcinogenesis. Genetic combined with bacterial and host genotyping may allow for the identification of patients at high risk of gastric cancer who can benefit from preventive eradication therapy. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2004        PMID: 15812151     DOI: 10.1159/000083590

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

1.  Quantitative assessment of the influence of prostate stem cell antigen polymorphisms on gastric cancer risk.

Authors:  Xixi Gu; Wen Zhang; Lili Xu; Dingfang Cai
Journal:  Tumour Biol       Date:  2013-10-22

Review 2.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery.

Authors:  Carl C Schimanski; Friederike Schlaegel; Mareike Jordan; Markus Moehler; George Sgourakis; Daniel G Drescher; Peter R Galle; Hauke Lang; Ines Gockel
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

4.  Novel findings about management of gastric cancer: a summary from 10th IGCC.

Authors:  Danila Penon; Letizia Cito; Antonio Giordano
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

5.  Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy?

Authors:  Daniel Drescher; Markus Moehler; Ines Gockel; Kirsten Frerichs; Annett Müller; Friedrich Dünschede; Thomas Borschitz; Stefan Biesterfeld; Martin Holtmann; Thomas Wehler; Andreas Teufel; Kerstin Herzer; Thomas Fischer; Martin R Berger; Theodor Junginger; Peter R Galle; Carl C Schimanski
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

6.  Association of Helicobacter pylori babA2 gene and gastric cancer risk: a meta-analysis.

Authors:  Marce-Amara Kpoghomou; Jinchen Wang; Tianpei Wang; Guanfu Jin
Journal:  BMC Cancer       Date:  2020-05-24       Impact factor: 4.430

7.  A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk.

Authors:  Francesco Gianfagna; Emma De Feo; Cornelia M van Duijn; Gualtiero Ricciardi; Stefania Boccia
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

8.  Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases.

Authors:  Alexander Desuki; Frank Staib; Ines Gockel; Markus Moehler; Hauke Lang; Stefan Biesterfeld; Annett Maderer; Peter R Galle; Martin R Berger; Carl C Schimanski
Journal:  Can J Gastroenterol Hepatol       Date:  2019-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.